Ticker Details
Biofrontera Inc.
IPO Date:	October 29, 2021
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$21.98M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.14 | 5.86%
Avg Daily Range (30 D):	$0.04 | 3.29%
Avg Daily Range (90 D):	$0.04 | 4.11%

Institutional Daily Volume
Avg Daily Volume:	1.42M
Avg Daily Volume (30 D):	.41M
Avg Daily Volume (90 D):	.3M

Trade Size
Avg Trade Size (Sh.):	277
Avg Trade Size (Sh.) (30 D):	366
Avg Trade Size (Sh.) (90 D):	367

Institutional Trades
Total Institutional Trades:	27
Avg Institutional Trade:	$1.17M
Avg Institutional Trade (30 D):	$2.12M
Avg Institutional Trade (90 D):	$2.12M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$.74M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	4.51K

News

Jul 3, 2026 @ 11:55 AM Photodynamic Therapy Market: Durable Growth with a... Source: Researchandmarkets.Com

May 8, 2026 @ 8:00 PM Biofrontera Inc. to Report First Quarter 2026 Fina... Source: Na

Dec 4, 2025 @ 2:00 PM Last Patient Completes Biofrontera’s Phase ... Source: Biofrontera Inc.

Aug 14, 2025 @ 7:01 PM Biofrontera Q2 Revenue Jumps 15% Source: Hermann Luebbert

Aug 13, 2025 @ 9:20 PM Biofrontera Inc. Reports Second Quarter 2025 Finan... Source: Hermann Luebbert

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.43	$-.05	$-.41
Diluted EPS	$-.45	$-.05	$-.41
Revenue	$46.18M	$12M	$10.08M
Gross Profit
Net Income / Loss	$-6.37M	$-.6M	$-4.75M
Operating Income / Loss	$-6.56M	$-.52M	$-4.32M
Cost of Revenue
Net Cash Flow	$.49M	$M	$M
PE Ratio

Splits
Jul 05, 2023	1:20